Every SEC Form 3/4/5 on record for this filer (CIK 1553338) — 5 issuers, 53 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | Director | 2016-08-10 → 2026-06-25 | 25 | −$8M |
| ANNX | Annexon, Inc. | Director | 2021-08-16 → 2026-06-15 | 7 | — |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Director | 2017-12-27 → 2025-12-23 | 17 | −$3M |
| TSBX | Turnstone Biologics Corp. | Director | 2024-04-16 → 2024-07-02 | 3 | — |
| CALA | Calithera Biosciences, Inc. | SR. VP & CFO · lapsed | 2015-07-16 → 2016-12-01 | 4 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PTGX | 2026-06-23 | Sell | 9,000 | $117.94 | $1M | 7,825 |
| PTGX | 2026-06-10 | Sell | 9,000 | $107.68 | $969,120 | 7,825 |
| PTGX | 2026-05-29 | Sell | 9,000 | $99.64 | $896,760 | 7,825 |
| PTGX | 2026-02-06 | Sell | 20,000 | $83.68 | $2M | 7,825 |
3 of 5 issuers are covered and open a security page; the rest are on file here only.
